In terms of cancer immune-related features, the ER signature score was positively correlated with and infiltration levels of anti-tumor immune-associated cells in SKCM, such as CD4 T cells and CD8 T cells (Figures 7G and 7H). This evidence concerns the gene CD8A and cancer.